SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-08-008902
Filing Date
2008-08-06
Accepted
2008-08-06 10:11:40
Documents
7
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y64662e10vq.txt 10-Q 109978
2 EX-10.12: SUPPLEMENTAL EXECUTIVE RETIREMENT CHANGE OF CONTROL AMENDMENT y64662exv10w12.txt EX-10.12 1406
3 EX-10.49: DIRECTORS' EQUITY PROGRAM y64662exv10w49.txt EX-10.49 1325
4 EX-31.1: CERTIFICATION y64662exv31w1.txt EX-31.1 4593
5 EX-31.2: CERTIFICATION y64662exv31w2.txt EX-31.2 4598
6 EX-32.1: CERTIFICATION y64662exv32w1.txt EX-32.1 1456
7 EX-32.2: CERTIFICATION y64662exv32w2.txt EX-32.2 1465
  Complete submission text file 0000950123-08-008902.txt   126215
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

IRS No.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10638 | Film No.: 08993606
SIC: 2834 Pharmaceutical Preparations